Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
77,143,980
-
Total 13F shares
-
33,136,833
-
Share change
-
+830,928
-
Total reported value
-
$1,089,462,176
-
Price per share
-
$32.88
-
Number of holders
-
67
-
Value change
-
+$26,868,072
-
Number of buys
-
37
-
Number of sells
-
23
Institutional Holders of Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX) as of Q4 2020
As of 31 Dec 2020 Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX) had 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 33,136,833 shares of stock of the company.
Largest 10 holders included TRV GP III, LLC, Column Group LLC, Redmile Group, LLC, WELLINGTON MANAGEMENT GROUP LLP, Foresite Capital Management IV, LLC, BAKER BROS. ADVISORS LP, EcoR1 Capital, LLC, Bain Capital Life Sciences Investors, LLC, BOXER CAPITAL, LLC, and BlackRock Inc..
This table shows 67 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.